Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2589-2593

  Scheffer, George L ^a   Maliepaard, Marc ^b   Pijnenborg, Adriana C L M ^a   Van Gastelen, Margôt A ^b   De Jong, Mariska C ^a   Schroeijers, Anouk B ^a   Van Der Kolk, Dorina M ^c   Allen, John D ^b   Ross, Douglas D ^d   Van Der Valk, Paul ^a   Dalton, William S ^e   Schellens, Jan H M ^b   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; IDARUBICIN; MITOXANTRONE; MONOCLONAL ANTIBODY; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MITOXANTRONE; NEOPLASM PROTEINS; TOPOTECAN; TUMOR CELLS, CULTURED;

EID: 18744421466     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Moscow, J. A., Schneider, E., Ivy, S. P., and Cowan, K. H. Multidrug resistance. Cancer Chemother. Biol. Response Modif. Annu., 17: 139-177, 1997.
2. Gottesman, M. M., Pastan, I., and Ambudkar, S. V. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev., 6: 610-617, 1996.
3. Cole, S. P., and Deeley, R. G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. BioEssays, 20: 931-940, 1998.
4. Paulusma, C. C. Bosma, P. J., Zaman, G. J., Bakker, C. T., Otter, M., Seheffer, G. L., Seheper, R. J., Borst, P., and Oude Elferink, R. P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Washington DC), 271: 1126-1128, 1996.
5. Kool, M., van der Linden, M., de Haas, M., Seheffer, G. L., de Vree, J. M. L., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Seheper, R. J., Oude Elferink, R. P. J., Baas, F., and Borst, P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA, 96: 6914-6919, 1999.
6. Doyle, L. A., Yang, W. D., Abruzzo, L. V., Krogmann, T., Gao, Y. M., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998.
7. Schneider, E., and Hunke, S. ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol. Rev., 22: 1-20, 1998.
8. Ross, D. D., Yang, W. D., Abruzzo, L. V. Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., and Doyle, L. A. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitroxantrone-selected cell lines. J. Natl. Cancer Inst., 91: 429-433, 1999.
9. Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C. A. M., Ruevekamp-Helmers, M. C., Floot, B. J., and Schellens, J. H. M. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res., 59: 4559-4563, 1999.
10. Taylor, C. W., Dalton, W. S., Parrish, P. R., Gleason, M. C., Bellamy, WT, Thompson, F. H., Roe, D. J., and Trent, J. M. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br. J. Cancer. 63: 923-929, 1991.
11. Hazlehurst, L. A., Foley, N. E., Gleason-Guzman, M. C., Hacker, M. P., Cress, A. E., Greenberger, L. W., de Jong, M. C., and Dalton, W. S. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res., 59: 1021-1028, 1999.
12. Rogan, A. M., Hamilton, T. C., Young, R. C., Klecker, R. W. J., Ozols, and RF Reversal of Adriamycin resistance by verapamil in human ovarian cancer. Science (Washington DC), 224: 994-996, 1984.
13. Eijdems, E. W., de Haas, M., Timmerman, A. J., Van der Schans, G. P., Kamst, E., de Nooij, J., Astaldi Ricotti, G. C., Borst, P., and Baas, F. Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines. Br. J. Cancer, 71: 40-47, 1995.
14. Withoff, S., De Vries, E. G. E. Keith, W. N., Nienhuis, E. F., van der Graaf, W. T. A., Uges, D. R. A., and Mulder, N. H. Differential expression of DNA topoisomerase II-α and -β in P-gp and MRP-negative, VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC(4). Br. J. Cancer, 74: 1869-1876, 1996.
15. Marsh, W., and Center, M. S. Adriamyein resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells. Cancer Res., 47: 5080-5086, 1987.
16. Allen, J. D., Brinkhuis, R. F., Wijnholds, J., and Schinkel, A. H. The mouse Bcrpl/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxoruhicin. Cancer Res., 59: 4237-1241, 1999.
17. Gluzman, Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell, 23: 175-182, 1981.
18. Aruffo, A., and Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA, 84: 8573-8577, 1987.
19. Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafal, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., and Borst, P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Investig., 101: 1310-1319, 1998.
20. Cui, Y. H., Konig, J., Buchholz, U., Spring, H., Leier, I., and Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol., 55: 929-937, 1999.